Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established
- PMID: 16861480
- PMCID: PMC2083040
- DOI: 10.1136/adc.2006.094870
Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established
Abstract
Perspective on the paper by Schmidt et al (see page 661)
Conflict of interest statement
Competing interests: none declared
Comment in
-
Positive benefit of postnatal treatment in congenital toxoplasmosis.Arch Dis Child. 2007 Jan;92(1):88-9. Arch Dis Child. 2007. PMID: 17185453 Free PMC article. No abstract available.
Comment on
-
The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.Arch Dis Child. 2006 Aug;91(8):661-5. doi: 10.1136/adc.2004.066514. Arch Dis Child. 2006. PMID: 16861484 Free PMC article.
References
-
- Guerina N G, Hsu H W, Meissner H C.et al Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 19943301858–1863. - PubMed
-
- Paul M, Petersen E, Pawlowski Z S.et al Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii‐specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J 20001930–36. - PubMed
-
- Vela‐Amieva M, Canedo‐Solares I, Gutierrez‐Castrellon P.et al Short report: neonatal screening pilot study of Toxoplasma gondii congenital infection in Mexico. Am J Trop Med Hyg 200572142–144. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical